CPhI 3rd Annual Global Pharma Regulatory Summit 2014 schedule

Wednesday 23rd April 2014

  • CPhI 3rd Annual Global Pharma Regulatory Summit 2014

    2013 has been a year of setbacks for the Indian pharma industry as the regulatory scrutiny has become tough, especially on Indian pharma companies because they have a bigger market share. It is, therefore, important for domestic companies to increase their investment in compliance of regulatory norms.

    Pharma is one sector where India is widely accepted to have manufacturing competence. If that credibility is eroded, current plans to boost pharma exports to $20 billion by 2020 will turn into a pipe dream. Thus the Indian pharma must turn proactive and consider a self-regulatory body.

    Keeping this in issue in mind, CPhI India brings to you the 3rd Annual Global Pharma Regulatory Summit to provide insights on the issues of regulatory compliance

    Whats New in 2014?
    This year we are focusing specifically on the nre and improved pharma regulations including

    Metallic & genotoxic impurities
    Stability Guidelines
    Refuse to Receive
    Regulatory procedural guidelines
    Quality by design as per the ICH Q8, Q9, Q10 and Q11.
    Harmonisation of guidelines – ROW

    Who should attend?

    Regulatory Head
    Regulatory Managers
    Regulatory Executives

    Price: INR:54,000, $1,509

    On Wednesday 23rd April

Schedule incomplete?

Add a new session

Filter by Day